Table 1. Prevalence of subjects with a long-term disease at 14 years of age.
| Category | Group | Conditions | All (N = 61,119) | Females (N = 29,860) | Males (N = 31,259) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| n | Pr, % | (95%CI) | n | Pr, % | (95%CI) | n | Pr, % | (95%CI) | |||
| All | All | All | 2,019 | 3.30 | (3.16;3.44) | 831 | 2.78 | (2.59;2.97) | 1,188 | 3.80 | (3.59;4.01) |
| Mental | All | All | 498 | 0.81 | (0.74;0.88) | 129 | 0.43 | (0.36;0.50) | 369 | 1.18 | (1.06;1.30) |
| Psychiatric diseases | Autism spectrum disorders | 166 | 0.27 | (0.23;0.31) | 39 | 0.13 | (0.09;0.17) | 127 | 0.41 | (0.34;0.48) | |
| Specific personality disorders | 120 | 0.20 | (0.16;0.24) | 28 | 0.09 | (0.06;0.12) | 92 | 0.29 | (0.23;0.35) | ||
| Psychotic disorders | 22 | 0.04 | (0.02;0.06) | 10 | 0.03 | (0.01;0.05) | 12 | 0.04 | (0.02;0.06) | ||
| Neurotic, emotional, mood disorders | 135 | 0.22 | (0.18;0.26) | 37 | 0.12 | (0.08;0.16) | 98 | 0.31 | (0.25;0.37) | ||
| Other psychological development disorder | 54 | 0.09 | (0.07;0.11) | 14 | 0.05 | (0.02;0.08) | 40 | 0.13 | (0.09;0.17) | ||
| Other psychiatric affections | 1 | 0.00 | (0.00;0.00) | 1 | 0.00 | (0.00;0.00) | 0 | 0.00 | (0.00;0.00) | ||
| Non-complex | All | All | 671 | 1.10 | (1.02;1.18) | 278 | 0.93 | (0.82;1.04) | 393 | 1.26 | (1.14;1.38) |
| Endocrine and metabolic diseases | Type 1 and type 2 diabetes | 114 | 0.19 | (0.16;0.22) | 48 | 0.16 | (0.11;0.21) | 66 | 0.21 | (0.16;0.26) | |
| Respiratory diseases | Persistent asthma | 235 | 0.38 | (0.33;0.43) | 88 | 0.29 | (0.23;0.35) | 147 | 0.47 | (0.39;0.55) | |
| Other serious chronic respiratory insufficiency | 17 | 0.03 | (0.02;0.04) | 8 | 0.03 | (0.01;0.05) | 9 | 0.03 | (0.01;0.05) | ||
| Vascular diseases | Chronic arteriopathies with ischemic manifestations | 3 | 0.00 | (0.00;0.00) | 3 | 0.01 | (0.00;0.02) | 0 | 0.00 | (0.00;0.00) | |
| Severe hypertension | 3 | 0.00 | (0.00;0.00) | 1 | 0.00 | (0.00;0.00) | 2 | 0.01 | (0.00;0.02) | ||
| Heart disease | Severe congenital heart disease | 110 | 0.18 | (0.15;0.21) | 48 | 0.16 | (0.11;0.21) | 62 | 0.20 | (0.15;0.25) | |
| Other heart diseases | 23 | 0.04 | (0.02;0.06) | 12 | 0.04 | (0.02;0.06) | 11 | 0.04 | (0.02;0.06) | ||
| Kidney diseases | Severe chronic kidney disease and primitive nephrotic syndrome | 47 | 0.08 | (0.06;0.10) | 24 | 0.08 | (0.05;0.11) | 23 | 0.07 | (0.04;0.10) | |
| Liver diseases | Active chronic liver disease and cirrhosis | 15 | 0.02 | (0.01;0.03) | 8 | 0.03 | (0.01;0.05) | 7 | 0.02 | (0.00;0.04) | |
| Inflammatory Bowel Disease | Progressive Crohn's disease and ulcerative colitis | 26 | 0.04 | (0.02;0.06) | 13 | 0.04 | (0.02;0.06) | 13 | 0.04 | (0.02;0.06) | |
| Malignancies | Malignant tumor, malignant disease of lymphatic tissue or blood | 78 | 0.13 | (0.10;0.16) | 25 | 0.08 | (0.05;0.11) | 53 | 0.17 | (0.12;0.22) | |
| Complex | All | All | 850 | 1.39 | (1.30;1.48) | 424 | 1.42 | (1.29;1.55) | 426 | 1.36 | (1.23;1.49) |
| Chromosome abnormalities | Down syndrome | 45 | 0.07 | (0.05;0.09) | 19 | 0.06 | (0.03;0.09) | 26 | 0.08 | (0.05;0.11) | |
| Other chromosome abnormalities | 15 | 0.02 | (0.01;0.03) | 10 | 0.03 | (0.01;0.05) | 5 | 0.02 | (0.00;0.04) | ||
| Neurological and muscular diseases | Cerebral palsy | 89 | 0.15 | (0.12;0.18) | 37 | 0.12 | (0.08;0.16) | 52 | 0.17 | (0.12;0.22) | |
| Paraplegia | 11 | 0.02 | (0.01;0.03) | 6 | 0.02 | (0.00;0.04) | 5 | 0.02 | (0.00;0.04) | ||
| Severe epilepsy | 94 | 0.15 | (0.12;0.18) | 45 | 0.15 | (0.11;0.19) | 49 | 0.16 | (0.12;0.20) | ||
| Other serious neurological and muscular diseases | 72 | 0.12 | (0.09;0.15) | 30 | 0.10 | (0.06;0.14) | 42 | 0.13 | (0.09;0.17) | ||
| Mental retardation | Mental retardation | 152 | 0.25 | (0.21;0.29) | 48 | 0.16 | (0.11;0.21) | 104 | 0.33 | (0.27;0.39) | |
| Immunodeficiencies | Severe primary immunodeficiency requiring prolonged treatment | 9 | 0.01 | (0.00;0.02) | 1 | 0.00 | (0.00;0.00) | 8 | 0.03 | (0.01;0.05) | |
| HIV infection | 15 | 0.02 | (0.01;0.03) | 6 | 0.02 | (0.00;0.04) | 9 | 0.03 | (0.01;0.05) | ||
| Medullary deficiencies and other chronic cytopenias | 3 | 0.00 | (0.00;0.00) | 1 | 0.00 | (0.00;0.00) | 2 | 0.01 | (0.00;0.02) | ||
| Hemolysis | Hemoglobinopathies | 17 | 0.03 | (0.02;0.04) | 6 | 0.02 | (0.00;0.04) | 11 | 0.04 | (0.02;0.06) | |
| Other constitutional chronic hemolysis, acquired hemolysis | 5 | 0.01 | (0.00;0.02) | 3 | 0.01 | (0.00;0.02) | 2 | 0.01 | (0.00;0.02) | ||
| Rheumatologic and systemic diseases | Progressive rheumatoid arthritis | 5 | 0.01 | (0.00;0.02) | 2 | 0.01 | (0.00;0.02) | 3 | 0.01 | (0.00;0.02) | |
| Juvenile arthritis | 16 | 0.03 | (0.02;0.04) | 8 | 0.03 | (0.01;0.05) | 8 | 0.03 | (0.01;0.05) | ||
| Progressive structural scoliosis | 139 | 0.23 | (0.19;0.27) | 124 | 0.42 | (0.35;0.49) | 15 | 0.05 | (0.03;0.07) | ||
| Vasculitis, systemic lupus erythematosus, systemic scleroderma | 3 | 0.00 | (0.00;0.00) | 2 | 0.01 | (0.00;0.02) | 1 | 0.00 | (0.00;0.00) | ||
| Hemorrhagic diseases | Hemophilia and serious constitutional disorders of hemostasis | 13 | 0.02 | (0.01;0.03) | 3 | 0.01 | (0.00;0.02) | 10 | 0.03 | (0.01;0.05) | |
| Purpura and other hemorrhagic conditions | 11 | 0.02 | (0.01;0.03) | 3 | 0.01 | (0.00;0.02) | 8 | 0.03 | (0.01;0.05) | ||
| Endocrine and metabolic diseases | Inherited metabolic diseases requiring prolonged treatment | 83 | 0.14 | (0.11;0.17) | 46 | 0.15 | (0.11;0.19) | 37 | 0.12 | (0.08;0.16) | |
| Respiratory diseases | Cystic fibrosis | 5 | 0.01 | (0.00;0.02) | 2 | 0.01 | (0.00;0.02) | 3 | 0.01 | (0.00;0.02) | |
| Vascular diseases | Disabling stroke | 21 | 0.03 | (0.02;0.04) | 11 | 0.04 | (0.02;0.06) | 10 | 0.03 | (0.01;0.05) | |
| Multiple diseases | Multiple diseases | 27 | 0.04 | (0.02;0.06) | 11 | 0.04 | (0.02;0.06) | 16 | 0.05 | (0.03;0.07) | |
Abbreviations: 95%CI, 95% confidence interval; Pr, prevalence